Laboratory tests Published · updated

Everything you need to know about the Panorama prenatal test (NIPT)

Panorama

PANORAMA is a genetic prenatal screening test, done on a blood sample, that detects common chromosomal conditions affecting the baby’s health. Panorama uses technology based on SNPs* to provide highly accurate results and unique insight into singleton and twin pregnancies.
Panorama can be done from as early as the ninth week of gestation. *SNP: single-nucleotide polymorphism

  1. Panorama

    • Trisomy 13 (Patau’s syndrome)

    • Trisomy 18 (Edwards’ syndrome)

    • Trisomy 21 (Down’s syndrome)

    • Sex chromosome abnormalities

    • Monosomy X (Turner syndrome), Klinefelter syndrome (XXY), triple X syndrome (XXX), Jacobs syndrome (XYY)

    • Triploidy – the presence of an extra set of chromosomes

    • The baby’s sex

  2. Panorama + DiGeorge syndrome

    • Panorama core panel

    • 22q11.2 DiGeorge syndrome

  3. Panorama + 5 microdeletions

    • Panorama core panel

    • 22q11

    • 1p36

    • Cri-du-chat

    • Angelman

    • Prader-Willi

Why choose the Panorama prenatal test?

It detects conditions that other tests cannot, including molar pregnancy, triploidy and a vanishing twin.

It assesses the risk of Down’s syndrome with an accuracy rate of over 99%.

It is the only test that distinguishes between the DNA of the pregnant woman and that of the fetus, which helps to avoid false positive and false negative results.

It is the only NIPT that can determine zygosity and the individual fetal fraction in a twin pregnancy.

Its sensitivity for the 22q11.2 microdeletion is over 83%. This common and potentially serious microdeletion affects pregnancies equally, regardless of the mother’s age.

It can be done for singleton and twin pregnancies, as well as for pregnancies achieved with donor eggs or through surrogacy.

It is the only prenatal test that can be done as early as the 9th week of gestation.

  • Validated in the largest prospective NIPT study

  • Technology with unique, clinically proven performance

  • Validated in SMART, the largest prospective NIPT study, with over 20,000 participants.

  • More than 3 million people in more than 60 countries have chosen Panorama for genetic testing during pregnancy.

  • Panorama has been evaluated in more than 25 peer-reviewed publications and in more than 1.3 million pregnancies.

  • The lowest fetal fraction that can be analysed is 2.8%, and the accuracy of sex determination is 100%.

  • Panorama is done with a simple blood sample from the pregnant woman and poses no risk to the pregnancy.

It detects common genetic conditions caused by extra or missing chromosomes in the fetus, such as Down’s syndrome, which is caused by extra copies of a particular chromosome, as well as microdeletions, which result from the loss of a small piece of genetic information. Because Panorama uses unique technology to distinguish between the DNA of the pregnant woman and that of the baby, it is the only NIPT that tests for triploidy and can avoid known sources of error that affect other NIPTs.

The latest ACOG recommendations (American College of Obstetricians and Gynecologists) support NIPT for all pregnancies and:

  • Recommend NIPT as an option to be ‘discussed and offered to all patients early in pregnancy, regardless of maternal age or baseline risk’.

  • Support cell-free DNA (cfDNA) analysis as ‘the most sensitive and specific screening test for the common fetal aneuploidies’.

  • Highlight the unique advantages of SNP-based NIPT, including the detection of triploidy and the unique ability to determine twin zygosity and the individual fetal fraction.

Zygosity detection

Recognised by the International Society for Prenatal Diagnosis (ISPD) as an important element in assessing NIPT results for twins

Individual fetal fraction for dizygotic twins

An important measure needed to interpret how reliable NIPT results are; ACOG recognises that, without this measurement, an aneuploidy could go undetected if the affected twin has a low fetal fraction

Determining the sex of the fetus

Panorama has made zero errors in determining the baby’s sex – in both singleton and twin pregnancies

In a validation study, Panorama identified monozygotic twins with >99% sensitivity and specificity.

Although chorionicity can be reliably determined in early pregnancy, studies have shown that up to 19% of monochorionic pregnancies are wrongly classified as dichorionic. Panorama allows doctors to match their ultrasound findings with an early and accurate determination of zygosity.

Identifying a monozygotic twin pregnancy with Panorama can prompt earlier, targeted ultrasound assessment of chorionicity and related complications such as twin-to-twin transfusion syndrome (TTTS).

The management of a twin pregnancy is strongly influenced by chorionicity; as such, determining zygosity with the Panorama prenatal test can help doctors to decide on the right plan for managing the pregnancy

Please note

Panorama is a screening test, which means that it does not give a final diagnosis. A high-risk result means that there is a higher chance of a specific genetic condition in the baby, but all medical decisions should be made after talking to your gynaecologist about further diagnostic testing during pregnancy, such as chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.

For more detailed information, call: 066 821 6197

Back to top